Lung cancer survival among never smokers
- PMID: 30851418
- DOI: 10.1016/j.canlet.2019.02.047
Lung cancer survival among never smokers
Abstract
Lung cancer incidence among never smokers has increased in recent decades with 10-30% of all lung cancers occurring in never smokers, where exposure to residential radon is the leading cause of this disease. Lung cancer survival is low, ranging from 12% to 16% at 5 years of diagnosis. There is scant evidence to date on survival from this disease in never smokers. We aim to evaluate lung cancer survival in never smokers and ascertain whether there might be differences regarding smokers, through a systematic review applying predefined inclusion and exclusion criteria. 17 Studies were included. Never-smoker lung cancer patients seem to experience longer survival times than do smokers or ex-smokers. Lung cancer in never smokers displays distinctive clinical characteristics, is more frequent among women, is diagnosed at more advanced stages, and the predominant histologic type is adenocarcinoma. Further studies are necessary to ascertain lung cancer survival among never smokers.
Keywords: Lung neoplasms; Never smokers; Survival.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study.Cancer Lett. 2020 Sep 1;487:21-26. doi: 10.1016/j.canlet.2020.05.022. Epub 2020 May 24. Cancer Lett. 2020. PMID: 32454144
-
Small-cell lung cancer in never-smokers.ESMO Open. 2021 Apr;6(2):100059. doi: 10.1016/j.esmoop.2021.100059. Epub 2021 Feb 26. ESMO Open. 2021. PMID: 33640828 Free PMC article.
-
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.Chest. 2004 Aug;126(2):347-51. doi: 10.1378/chest.126.2.347. Chest. 2004. PMID: 15302716
-
Residential radon exposure and lung cancer: risk in nonsmokers.Health Phys. 2002 Jul;83(1):1-18. doi: 10.1097/00004032-200207000-00001. Health Phys. 2002. PMID: 12075673 Review.
-
Residential radon and small cell lung cancer. A systematic review.Cancer Lett. 2018 Jul 10;426:57-62. doi: 10.1016/j.canlet.2018.04.003. Epub 2018 Apr 11. Cancer Lett. 2018. PMID: 29654890
Cited by
-
Expression and clinical significance of microRNA-21, PTEN and p27 in cancer tissues of patients with non-small cell lung cancer.Oncol Lett. 2020 Oct;20(4):49. doi: 10.3892/ol.2020.11910. Epub 2020 Jul 24. Oncol Lett. 2020. PMID: 32802169 Free PMC article.
-
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers.Cell Rep Med. 2023 Jun 20;4(6):101078. doi: 10.1016/j.xcrm.2023.101078. Epub 2023 Jun 9. Cell Rep Med. 2023. PMID: 37301197 Free PMC article.
-
Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021.EClinicalMedicine. 2024 Sep 5;75:102804. doi: 10.1016/j.eclinm.2024.102804. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39290907 Free PMC article.
-
A triple-classification for the evaluation of lung nodules manifesting as pure ground-glass sign: a CT-based radiomic analysis.BMC Med Imaging. 2022 Jul 27;22(1):133. doi: 10.1186/s12880-022-00862-x. BMC Med Imaging. 2022. PMID: 35896975 Free PMC article.
-
PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming.J Exp Clin Cancer Res. 2022 Jul 22;41(1):229. doi: 10.1186/s13046-022-02437-8. J Exp Clin Cancer Res. 2022. PMID: 35869499 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
